NCT04320030View on ClinicalTrials.gov

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 11, 2020

Primary Completion Date

July 21, 2021

Study Completion Date

July 21, 2021

Conditions
Triple Negative Breast Cancer
Interventions
DRUG

[18F]-DPA-714 PET/CT scan

Pretherapeutic \[18F\]-DPA-714 PET/CT scan

Trial Locations (3)

37044

CHU Bretonneau, Tours

44805

Institut de cancerologie de l'Ouest, Saint-Herblain

75020

APHP - Hôpital Tenon, Paris

All Listed Sponsors
collaborator

SIRIC ILIAD

UNKNOWN

lead

Institut Cancerologie de l'Ouest

OTHER

NCT04320030 - [18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers | Biotech Hunter | Biotech Hunter